Oral treatment with an antioxidant (raxofelast) reduces oxidative stress and improves endothelial function in men with Type II diabetes
P. J. Chowienczyk, S. E. Brett, N. K. Gopaul, D. Meeking, M. Marchetti, D. L. Russell-Jones, E. E. Änggård, J. M. RitterVolume:
43
Language:
english
Pages:
4
DOI:
10.1007/s001250051478
Date:
August, 2000
File:
PDF, 76 KB
english, 2000